A listing of will-simon medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
What is this study about?The goals of this clinical study are to learn about the safety, tolerability, dosing andveness of the study drug, magrolimab in combination with other anticancer therapies inwith head and neck squamous cell carcinoma (HNSCC). THIS STUDY IS ENROLLING BY INVITATION ONLY - Consistent with most oncology …
The purpose of this study is to obtain and store specimens (tissue, blood, urine, or saliva) from subjects without diagnosed breast cancer compared to subjects with breast cancer.
The purpose of this study is to test the impact of a web-based resource, the Cancer Care Road Map Goal Activity, designed to help people with advanced cancer identify, evaluate, and communicate their most important goals during treatment or care planning. We will assess how often patients access the resource …
What is this study about?The major purpose of this research study is to obtain blood samples from child and adult patients diagnosed with thymoma and/or tissue samples from patients undergoing surgery for their thymoma. We will use these specimens to test for certain characteristics that we think will be useful …
The primary goal of this study is to determine the prevalence of cancer cachexia in patients with head and neck cancer undergoing surgery at Indiana University
An unmet need remains to provide culturally and linguistically competent healthcare both at the legislative and implementation levels. Our hypothesis is that capturing PROs in patients’ native language would overcome the barriers inherent to physician-patient language discordance
The purpose of this study is to learn more about the financial burden of cancer treatment, and how it affects patients with cancer. Researchers will use this information to improve support services for patients in the future.
The objective of the ROWAN clinical study is to assess the efficacy of local tumor control in HCC patients who receive TheraSphere followed by durvalumab and tremelimumab.